SCHEMBL29910146

SCHEMBL29910146

CC(C)(C)OC(=O)Nc1cccc(C(F)F)c1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RXFP1 Q9HBX9 1/20 0.48
MEN1 O00255 1/20 0.48
KMT2A Q03164 1/20 0.48
HDAC3 O15379 1/20 0.47
HDAC1 Q13547 1/20 0.47
HDAC2 Q92769 1/20 0.47
HDAC8 Q9BY41 1/20 0.47
HDAC6 Q9UBN7 1/20 0.47
CYP17A1 P05093 1/20 0.46
IDO1 P14902 1/20 0.46
SYK P43405 1/20 0.45
HPGD P15428 1/20 0.44
ALOX15 P16050 1/20 0.44
PRMT5 O14744 1/20 0.43
WDR77 Q9BQA1 1/20 0.43
CA12 O43570 1/20 0.43
CA1 P00915 1/20 0.43
CA9 Q16790 1/20 0.43
NAMPT P43490 1/20 0.43
KDR P35968 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28360251 1.00 RXFP1 (0.48) RXFP1MEN1KMT2AHDAC3HDAC1
SCHEMBL12743181 0.90 FADS1 (0.51) RXFP1MEN1KMT2AHDAC3HDAC1
SCHEMBL21377414 0.88 MEN1 (0.63) RXFP1MEN1KMT2AHDAC3HDAC1
SCHEMBL28032815 0.88 MEN1 (0.63) RXFP1MEN1KMT2AHDAC3HDAC1
SCHEMBL13734965 0.88 MEN1 (0.63) RXFP1MEN1KMT2AHDAC3HDAC1
SCHEMBL546162 0.87 MEN1 (0.47) RXFP1MEN1KMT2AHDAC3HDAC1
SCHEMBL13735757 0.87 MEN1 (0.47) RXFP1MEN1KMT2AHDAC3HDAC1
SCHEMBL19426702 0.87 IDO1 (0.49) RXFP1MEN1KMT2AHDAC3HDAC1
SCHEMBL4396277 0.86 PTGS1 (0.48) RXFP1MEN1KMT2AHDAC3HDAC1
SCHEMBL29800023 0.86 PTGS1 (0.48) RXFP1MEN1KMT2AHDAC3HDAC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220289720-A1 ARYL SULFONAMIDES AS SMALL MOLECULE STAT3 INHIBITORS UNIVERSITY OF HAWAII 2022-09-15 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220289720-A1 ARYL SULFONAMIDES AS SMALL MOLECULE STAT3 INHIBITORS STAT3, JAK2, STAT6 RXFP1 3156/4885MEN1 4749/4885KMT2A 611/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.